Latest News about jnj
Recent news which mentions jnj
The Meta meltdown: This chart shows Facebook’s fall from grace among the most valuable U.S. companies
September 13, 2022
From MarketWatch
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
From Benzinga
Jupiter Wellness's Booster Drug Has Potential To Increase Hair Loss Treatments' Efficacy By Enhancing Crucial Enzyme Enrichment Capacity by 7x
September 13, 2022
From Benzinga
From Benzinga
Johnson & Johnson Reaches $300M Settlement In Australian Pelvic Mesh Lawsuit
September 12, 2022
Tickers
JNJ
From Benzinga
3 Dividend Aristocrats Set to Win Big From Unstoppable Trends
September 11, 2022
From Motley Fool
Big investors are favoring large-cap stocks for the rest of 2022 — maybe you should too
September 09, 2022
From MarketWatch
From Benzinga
The Best Warren Buffett Stocks to Buy With $300 Right Now
September 08, 2022
From Motley Fool
The Smartest Dividend Stocks to Buy With $400 Right Now
September 07, 2022
From Motley Fool
7 Dow Stocks With Superior Fundamentals
September 06, 2022
From InvestorPlace
3 Great Dividend Stocks to Buy in September
September 03, 2022
From Motley Fool
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
Is Veeva Systems Stock a Buy Now?
September 02, 2022
From Motley Fool
This Foreboding Sign Looms Over Johnson & Johnson's Chart
September 02, 2022
Tickers
JNJ
From Benzinga
Johnson & Johnson To Settle New Hampshire Opioid Lawsuit With Payment Of $40.5M: Report
September 02, 2022
Tickers
JNJ
From Benzinga
If You Invested $10,000 in Johnson & Johnson 5 Years Ago, This Is How Much You Would Have Today
September 02, 2022
Tickers
JNJ
From Motley Fool
3 Warren Buffett Stocks to Buy Hand Over Fist In September
September 02, 2022
From Motley Fool
From Benzinga
These 2 dividend-stock funds use different strategies that work well in tough market times
August 30, 2022
From MarketWatch
Why Bristol Myers Squibb Stock Is Slumping Today
August 29, 2022
From Motley Fool
Bristol Myers-JNJ Partnered Secondary Stroke Drug Misses Endpoint, But Companies See Enough Potential For Phase 3 Trials
August 29, 2022
From Benzinga
From Motley Fool
Worried About a Recession? Buy These 2 Warren Buffett Stocks.
August 26, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.